Bausch + Lomb Nl company information, Employees & Contact Information

Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report Stocktwits

Bausch + Lomb identifies issue in enVista platform, returns product to market Ophthalmology Times

Bausch Health: Repricing Continues As Deleveraging Gains Traction (NYSE:BHC) Seeking Alpha

Richard Bausch Thinks You Can Never Permanently Ruin a Piece of Writing (And Other Tidbits) Literary Hub

Historic Tudor Mansion Built for Bausch & Lomb Heiress Hits the Market in Upstate New York for $3.2 Million Realtor.com

FDA elevates intraocular lens recall as Bausch + Lomb identifies cause Fierce Biotech

Bausch Health Learns Icahn Has 34% Economic Interest in Shares The Wall Street Journal

Bausch + Lomb to remain public amid deal negotiations of sale Optometry Times

After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale Fierce Pharma

Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine Business Wire

Bausch + Lomb on specialty contact lenses Association of Optometrists (AOP)

Bausch + Lomb acquires Whitecap Biosciences Ophthalmology Times

Potential CooperVision–Bausch + Lomb merger floated by investor Rochester Business Journal

Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat Yahoo Finance

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio PR Newswire

Bausch + Lomb considers sale: FT MedTech Dive

Kristin Bausch and Chris Vazquez Join The Marshall Project as Audience Engagement Producers The Marshall Project

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options Ophthalmology Times

Bausch + Lomb builds out dry eye awareness push with new survey, patient stories Fierce Pharma

Bausch Health Companies Inc. (BHC): A Bull Case Theory Yahoo Finance

FDA approves Bausch + Lomb’s enVista Envy range of IOLs Ophthalmology Times

Bausch + Lomb will resume intraocular lens sales weeks after recall MedTech Dive

Bausch + Lomb Continues Deal Streak With $106M Acquisition of J&J Eye Drops MedCity News

Bausch Health bags phase 3-ready liver prospect in $63M Durect buyout Fierce Biotech

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors Yahoo Finance

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel Yahoo Finance

Bausch + Lomb voluntarily recalls select enVista IOLs Optometry Times

Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut Reuters

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent Yahoo Finance

Dr. Lawrence Charles Bausch Heafey Hoffmann Dworak Cutler

Eyecare company Bausch + Lomb explores sale to end messy spin-off Financial Times

FDA Approves Bausch + Lomb Drug With a New Approach to Dry Eye Disease MedCity News

Billionaire Carl Icahn builds 34% economic interest in Bausch Health Reuters

TPG and Blackstone team up to bid for eyecare group Bausch + Lomb Financial Times

In a Novel About Theater, the Most Fraught Dramas Are Offstage (Published 2023) The New York Times

Bausch + Lomb Broadens Eye Products Lineup Via $1.75B Deal With Novartis MedCity News

Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in? Yahoo Finance

Bausch + Lomb to spin off eye care business 13wham.com

Novartis sells off dry eye disease med Xiidra, other ophthalmology assets to Bausch + Lomb for $2.5B Fierce Pharma

Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid Investopedia

Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors CNBC

Bausch + Lomb’s uncertain future Rochester Beacon

Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential Yahoo Finance

Bausch, Teva accused of delaying generic version of diarrhea drug Xifaxan Reuters

US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug Reuters

Bausch + Lomb Sinks After Disclosing It Won’t Go Private Now Bloomberg.com

Bausch + Lomb buyout teeters as Blackstone balks at price tag Financial Times

Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? Investor's Business Daily

How Richard Bausch learned to stop worrying and trust his instincts Los Angeles Times

Pina Bausch’s ‘Rite of Spring’ Takes Root in Africa (Published 2023) The New York Times

The Afterlife of Pina Bausch The New Yorker

Bausch Plan to Spin Off Eye-Care Business Stuck in Creditor Standoff The Wall Street Journal

Bausch Health pulls the plug on Solta Medical IPO and 3-way company split Fierce Biotech

Valeant Will Become Bausch Health Companies Inc. PR Newswire

Review: Pina Bausch’s Vollmond – you've got to see it to believe it Gramilano

Forever (Immersion dans Café Müller de Pina Bausch) review – a heartbreaking redux The Guardian

Valeant, Distancing Itself From Its Past, Will Change Its Name to Bausch Health (Published 2018) The New York Times

Nelken review – new generation restores the bloom of Pina Bausch’s classic The Guardian

Review: The Ghosts and Rites of Pina Bausch (Published 2017) The New York Times

The Aesthetic Language of Choreographer Pina Bausch AnOther Magazine

Pina Bausch IMDb

Pina Bausch’s Last Dance The New Yorker

Strength in the SWOT Analysis of Bausch and Lomb : Marketing91

The sound of Pina Bausch The Guardian

Pina Bausch tributes: 'She got the keys to your soul' The Guardian

Farewell to Pina Bausch, the dangerous magician of modern dance The Guardian

Obituary: Pina Bausch The Guardian

Pina Bausch, German choreographer and dancer, dies The Guardian

Meeting Pina Bausch The Arts Desk |

PINA BAUSCH DANCE: KEY IS EMOTION (Published 1985) The New York Times